HSBA

879.5

+0.79%↑

BARC

332.6

+1.96%↑

LLOY

76.92

+0.58%↑

RBS

527.6

+1.38%↑

FLTR.UK

18,430

+2.73%↑

HSBA

879.5

+0.79%↑

BARC

332.6

+1.96%↑

LLOY

76.92

+0.58%↑

RBS

527.6

+1.38%↑

FLTR.UK

18,430

+2.73%↑

HSBA

879.5

+0.79%↑

BARC

332.6

+1.96%↑

LLOY

76.92

+0.58%↑

RBS

527.6

+1.38%↑

FLTR.UK

18,430

+2.73%↑

HSBA

879.5

+0.79%↑

BARC

332.6

+1.96%↑

LLOY

76.92

+0.58%↑

RBS

527.6

+1.38%↑

FLTR.UK

18,430

+2.73%↑

HSBA

879.5

+0.79%↑

BARC

332.6

+1.96%↑

LLOY

76.92

+0.58%↑

RBS

527.6

+1.38%↑

FLTR.UK

18,430

+2.73%↑

Search

ConvaTec Group PLC

Closed

SectorFinance

295.6 0.34

Overview

Share price change

24h

Current

Min

295.6

Max

296.8

Key metrics

By Trading Economics

Income

33M

112M

Sales

62M

1.2B

P/E

Sector Avg

41.543

24.968

EPS

0.07

Dividend yield

1.75

Profit margin

9.517

Employees

10,489

EBITDA

38M

289M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+9.31% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.75%

4.18%

Next Earnings

29 lip 2025

Next Ex Dividend date

21 sie 2025

Market Stats

By TradingEconomics

Market Cap

890M

5.9B

Previous open

295.26

Previous close

295.6

News Sentiment

By Acuity

50%

50%

205 / 538 Ranking in Finance

ConvaTec Group PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

26 lut 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Peer Comparison

Price change

ConvaTec Group PLC Forecast

Price Target

By TipRanks

9.31% upside

12 Months Forecast

Average 322.9 GBX  9.31%

High 390 GBX

Low 300 GBX

Based on 10 Wall Street analysts offering 12 month price targets forConvaTec Group PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

8

Buy

2

Hold

0

Sell

Sentiment

By Acuity

205 / 538 Ranking in Finance

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.